VIMOVO 500mg / 20mg modified release tablets medication leaflet

M01AE52 naproxen + esomeprazole • Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives

Naproxen + esomeprazole is a combination medication used to treat pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, while reducing the risk of gastrointestinal complications caused by nonsteroidal anti-inflammatory drugs (NSAIDs).

- Naproxen is an NSAID that reduces pain, inflammation, and fever by inhibiting prostaglandin production.
- Esomeprazole is a proton pump inhibitor (PPI) that decreases stomach acid production, protecting the stomach lining from irritation and ulcers caused by naproxen.

This combination is particularly indicated for patients at higher risk of gastric ulcers or gastrointestinal bleeding.

Side effects may include nausea, stomach pain, diarrhea, dizziness, or, in rare cases, allergic reactions. Long-term use may increase the risk of cardiovascular events (due to naproxen) or gastrointestinal infections (due to reduced stomach acid). It is important to take this medication as prescribed by a doctor.

VIMOVO 500mg/20mg modified release tablets GRÜNENTHAL GMBH, naproxen+esomeprazole

General data about VIMOVO 500mg / 20mg

Substance: naproxen + esomeprazole

Date of last drug list: 01-06-2025

Commercial code: W68965029

Concentration: 500mg / 20mg

Pharmaceutical form: modified release tablets

Quantity: 30

Product type: original

Price: 65.15 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ASTRAZENECA AB - SUEDIA

Holder: GRÜNENTHAL GMBH - GERMANIA

Number: 9516/2016/29

Shelf life: 2 years

Compensation lists for VIMOVO 500mg / 20mg GRÜNENTHAL GMBH

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

65.15 RON

27.92 RON

37.23 RON